Prescription drug · NDA AUTHORIZED GENERIC
Fluticasone Propionate and Salmeterol NDC 50090-3387
Fluticasone propionate 232 ug/1; Salmeterol xinafoate 14 ug/1 · Powder, Metered · Respiratory (Inhalation) · A-S Medication Solutions
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 50090-3387-0 | 50090338700 | 1 POUCH in 1 CARTON (50090-3387-0) / 1 POWDER, METERED in 1 POUCHMarketed from Mar 5, 2018 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Fluticasone Propionate and Salmeterol
- Generic name (nonproprietary)
- fluticasone propionate and salmeterol
- Active ingredients
- Fluticasone propionate — 232 ug/1Salmeterol xinafoate — 14 ug/1
- Dosage form
- Powder, Metered
- Route
- Respiratory (Inhalation)
- Labeler
- A-S Medication Solutions
- Product type
- Prescription drug
- Marketing category
- NDA authorized genericApplication NDA 208799
- Marketing start
- Listing expires
- Other FDA classes
- Adrenergic beta2-Agonists (Mechanism)Corticosteroid Hormone Receptor Agonists (Mechanism)
- Identifiers
- Product ID 50090-3387_4bf35a9c-39b0-4293-a1ae-5a1d1bc97c48SPL ID 4bf35a9c-39b0-4293-a1ae-5a1d1bc97c48SPL set ID 77269609-fb89-47c7-97cc-22e0183e91aeRxCUI 1918194, 1918203, 1918209UNII 6EW8Q962A5, O2GMZ0LF5W
- Pharmacologic class
- Corticosteroid; beta2-Adrenergic Agonist
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- NDC on a medical claim
N450090338700followed by a unit qualifier and the quantityPackage 50090-3387-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler (FS MDPI) is indicated for the treatment of asthma in adult and pediatric patients aged 12 years and older. Fluticasone Propionate/Salmeterol MDPI should be used for patients not adequately controlled on a long term asthma control medication such as an inhaled corticosteroid or whose disease warrants initiation of treatment with both an inhaled corticosteroid and long acting beta 2 -adrenergic agonist (LABA). Limitations of Use : Fluticasone Propionate/Salmeterol MDPI is not indicated for the relief of acute bronchospasm. Fluticasone Propionate/Salmeterol Multi-Dose Dry Powder Inhaler (MDPI) is a combination of fluticasone propio…
Excerpt only. Read the full label for complete information.
Other NDCs under NDA 208799
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| AirDuo RespiClickfluticasone propionate and salmeterol | Fluticasone propionate 55 ug/1; Salmeterol xinafoate 14 ug/1 | Powder, MeteredRespiratory (Inhalation) | Teva Respiratory, LLC | 59310-805 |
| AirDuo RespiClickfluticasone propionate and salmeterol | Fluticasone propionate 113 ug/1; Salmeterol xinafoate 14 ug/1 | Powder, MeteredRespiratory (Inhalation) | Teva Respiratory, LLC | 59310-812 |
| AirDuo RespiClickfluticasone propionate and salmeterol | Fluticasone propionate 232 ug/1; Salmeterol xinafoate 14 ug/1 | Powder, MeteredRespiratory (Inhalation) | Teva Respiratory, LLC | 59310-822 |
| Fluticasone Propionate and Salmeterol | Fluticasone propionate 55 ug/1; Salmeterol xinafoate 14 ug/1 | Powder, MeteredRespiratory (Inhalation) | Teva Pharmaceuticals USA, Inc. | 0093-3607 |
| Fluticasone Propionate and Salmeterol | Fluticasone propionate 113 ug/1; Salmeterol xinafoate 14 ug/1 | Powder, MeteredRespiratory (Inhalation) | Teva Pharmaceuticals USA, Inc. | 0093-3608 |
| Fluticasone Propionate and Salmeterol | Fluticasone propionate 113 ug/1; Salmeterol xinafoate 14 ug/1 | Powder, MeteredRespiratory (Inhalation) | Bryant Ranch Prepack | 63629-8809 |
| Fluticasone Propionate and Salmeterol | Fluticasone propionate 232 ug/1; Salmeterol xinafoate 14 ug/1 | Powder, MeteredRespiratory (Inhalation) | Bryant Ranch Prepack | 63629-8810 |
| Fluticasone Propionate and Salmeterol | Fluticasone propionate 55 ug/1; Salmeterol xinafoate 14 ug/1 | Powder, MeteredRespiratory (Inhalation) | Bryant Ranch Prepack | 63629-8811 |
| Fluticasone Propionate and Salmeterol | Fluticasone propionate 232 ug/1; Salmeterol xinafoate 14 ug/1 | Powder, MeteredRespiratory (Inhalation) | Teva Pharmaceuticals USA, Inc. | 0093-3609 |
| Fluticasone Propionate and Salmeterol | Fluticasone propionate 113 ug/1; Salmeterol xinafoate 14 ug/1 | Powder, MeteredRespiratory (Inhalation) | A-S Medication Solutions | 50090-3271 |
| Fluticasone Propionate and Salmeterol | Fluticasone propionate 55 ug/1; Salmeterol xinafoate 14 ug/1 | Powder, MeteredRespiratory (Inhalation) | A-S Medication Solutions | 50090-3272 |